10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,730,609 | -29.4% | 90,439 | -4.5% | 0.04% | -4.3% |
| Q2 2023 | $5,286,708 | -3.3% | 94,676 | -3.4% | 0.05% | -13.2% |
| Q1 2023 | $5,469,094 | +42.6% | 98,030 | -6.8% | 0.05% | +32.5% |
| Q4 2022 | $3,834,290 | -99.7% | 105,222 | +96.0% | 0.04% | +135.3% |
| Q3 2022 | $1,529,262,000 | +57760.8% | 53,696 | -8.1% | 0.02% | -34.6% |
| Q2 2022 | $2,643,000 | -42.6% | 58,417 | -3.6% | 0.03% | -27.8% |
| Q1 2022 | $4,608,000 | -76.6% | 60,570 | -54.2% | 0.04% | -50.7% |
| Q4 2021 | $19,700,000 | +1257.7% | 132,246 | +1226.8% | 0.07% | +386.7% |
| Q3 2021 | $1,451,000 | -16.0% | 9,967 | +13.0% | 0.02% | -21.1% |
| Q2 2021 | $1,728,000 | +68.8% | 8,823 | +56.0% | 0.02% | +46.2% |
| Q1 2021 | $1,024,000 | – | 5,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |